| Product NDC: | 51079-294 |
| Proprietary Name: | Tamsulosin Hydrochloride |
| Non Proprietary Name: | tamsulosin hydrochloride |
| Active Ingredient(s): | .4 mg/1 & nbsp; tamsulosin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-294 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090408 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121228 |
| Package NDC: | 51079-294-19 |
| Package Description: | 25 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-294-19) > 1 CAPSULE in 1 BLISTER PACK (51079-294-17) |
| NDC Code | 51079-294-19 |
| Proprietary Name | Tamsulosin Hydrochloride |
| Package Description | 25 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-294-19) > 1 CAPSULE in 1 BLISTER PACK (51079-294-17) |
| Product NDC | 51079-294 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tamsulosin hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121228 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | TAMSULOSIN HYDROCHLORIDE |
| Strength Number | .4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |